Statutory Accounts for the Half Year Ended 31 Dec 2020
Filed with ASX · · 27 pages · English
As approved by the Board of CSL Limited, and in accordance with ASX Listing Rule 4.2A, please find attached the following documents for the half year ended 31 December 2020: Appendix 4D; Directors’ Report; and Financial Report. These documents should be read in conjunction with the 30 June 2020 CSL Annual Report (accessible in the “Investor” section of CSL’s website (www.CSL.com) under the tab “Fi
Earlier from CSL
- Dividend/Distribution - CSL
- Update on UQ-CSL v451 COVID-19 Vaccine
- Chairmans Address to Shareholders
- CSL Supply Agreement for UQ Vaccine with Commonwealth
- Statutory Accounts for the Full Year Ended 30 June 2020
Later from CSL
- Update on CSL Agreement with uniQure
- CSL Statutory Accounts for the Full Year Ended 30 June 2021
- Trading Halt
- Swiss tender offer to acquire 100% of vifor pharma ltd
- Investor Presentation CSL Swiss Tender Acquisition of Vifor
Follow CSL into a list and get an email when it puts out news.
Follow CSL